tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports
Want to see ABUS full AI Analyst Report?

Arbutus Biopharma (ABUS) Ratios

1,273 Followers

Arbutus Biopharma Ratios

ABUS's free cash flow for Q1 2026 was $1.00. For the 2026 fiscal year, ABUS's free cash flow was decreased by $ and operating cash flow was $0.94. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 54.26 15.73 8.15 5.87 4.60
Quick Ratio
 54.26 15.73 8.15 5.87 4.60
Cash Ratio
 4.64 3.00 2.33 1.17 0.94
Solvency Ratio
 9.46 -1.84 -2.00 -1.86 -1.16
Operating Cash Flow Ratio
 -6.73 -6.60 -4.15 -3.82 -1.08
Short-Term Operating Cash Flow Coverage
 -54.45 -72.46 0.00 0.00 -95.04
Net Current Asset Value
$ 260.02M$ 76.41M$ 92.97M$ 93.64M$ 92.57M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.04 <0.01 0.06 0.06
Debt-to-Equity Ratio
 <0.01 0.05 0.01 0.08 0.09
Debt-to-Capital Ratio
 <0.01 0.05 0.01 0.08 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.04 0.00 0.06 0.07
Financial Leverage Ratio
 1.07 1.24 1.35 1.36 1.43
Debt Service Coverage Ratio
 218.06 -41.44 -499.29 -154.65 -31.60
Interest Coverage Ratio
 1.80K -278.88 -557.07 -170.16 -37.92
Debt to Market Cap
 <0.01 <0.01 0.00 0.02 0.03
Interest Debt Per Share
 <0.01 0.02 <0.01 0.06 0.09
Net Debt to EBITDA
 -0.15 0.52 0.51 0.25 0.29
Profitability Margins
Gross Profit Margin
99.98%97.42%100.00%100.00%100.00%
EBIT Margin
81.64%-192.08%-1130.82%-399.04%-162.19%
EBITDA Margin
81.67%-189.51%-1108.46%-391.30%-158.54%
Operating Profit Margin
80.79%-192.08%-1236.74%-430.53%-167.75%
Pretax Profit Margin
83.95%-237.88%-1133.04%-401.57%-166.62%
Net Profit Margin
83.95%-237.88%-1133.04%-401.57%-178.01%
Continuous Operations Profit Margin
83.95%-237.88%-1133.04%-401.57%-178.01%
Net Income Per EBT
100.00%100.00%100.00%100.00%106.84%
EBT Per EBIT
103.91%123.84%91.62%93.27%99.32%
Return on Assets (ROA)
57.99%-35.41%-53.09%-50.45%-35.54%
Return on Equity (ROE)
129.32%-43.75%-71.81%-68.71%-50.75%
Return on Capital Employed (ROCE)
56.85%-30.53%-65.74%-64.06%-40.27%
Return on Invested Capital (ROIC)
56.72%-30.34%-65.47%-63.84%-40.17%
Return on Tangible Assets
57.99%-35.41%-53.09%-50.45%-35.54%
Earnings Yield
19.56%-3.64%-11.52%-17.56%-19.75%
Efficiency Ratios
Receivables Turnover
 145.92 8.06 2.56 10.21 28.86
Payables Turnover
 0.02 0.31 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 8.70K 440.09 1.42 2.98 5.73
Asset Turnover
 0.69 0.15 0.05 0.13 0.20
Working Capital Turnover Ratio
 1.06 0.14 0.06 0.16 0.29
Cash Conversion Cycle
 -16.17K -1.13K 142.49 35.73 12.65
Days of Sales Outstanding
 2.50 45.28 142.49 35.73 12.65
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 16.17K 1.18K 0.00 0.00 0.00
Operating Cycle
 2.50 45.28 142.49 35.73 12.65
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.18 -0.21 -0.35 -0.52 -0.23
Free Cash Flow Per Share
 -0.18 -0.21 -0.35 -0.52 -0.24
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 -8.59M 0.00 -356.32 -85.25 -69.05
Capital Expenditure Coverage Ratio
 -8.59M 0.00 -356.32 -85.25 -69.05
Operating Cash Flow Coverage Ratio
 -54.45 -9.46 -50.31 -9.85 -2.82
Operating Cash Flow to Sales Ratio
 -0.18 -2.81 -10.51 -4.74 -0.91
Free Cash Flow Yield
-4.10%-4.30%-10.71%-20.96%-10.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 5.11 -27.51 -8.68 -5.70 -5.06
Price-to-Sales (P/S) Ratio
 4.37 65.44 98.35 22.87 9.01
Price-to-Book (P/B) Ratio
 3.16 12.04 6.23 3.91 2.57
Price-to-Free Cash Flow (P/FCF) Ratio
 -24.38 -23.25 -9.33 -4.77 -9.81
Price-to-Operating Cash Flow Ratio
 -23.91 -23.25 -9.36 -4.83 -9.95
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.50 0.64 1.31 0.14
Price-to-Fair Value
 3.16 12.04 6.23 3.91 2.57
Enterprise Value Multiple
 5.21 -34.01 -8.36 -5.60 -5.39
Enterprise Value
 814.48M 907.77M 571.90M 397.34M 333.46M
EV to EBITDA
 5.21 -34.01 -8.36 -5.60 -5.39
EV to Sales
 4.25 64.46 92.68 21.90 8.55
EV to Free Cash Flow
 -23.71 -22.90 -8.79 -4.57 -9.30
EV to Operating Cash Flow
 -23.71 -22.90 -8.82 -4.62 -9.43
Tangible Book Value Per Share
 1.34 0.40 0.52 0.64 0.91
Shareholders’ Equity Per Share
 1.34 0.40 0.52 0.64 0.91
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.07
Revenue Per Share
 0.99 0.07 0.03 0.11 0.26
Net Income Per Share
 0.83 -0.17 -0.38 -0.44 -0.46
Tax Burden
 1.00 1.00 1.00 1.00 1.07
Interest Burden
 1.03 1.24 1.00 1.01 1.03
Research & Development to Revenue
 0.11 1.79 8.76 4.06 2.16
SG&A to Revenue
 0.08 1.13 3.58 1.24 0.46
Stock-Based Compensation to Revenue
 0.10 0.49 1.46 0.51 0.18
Income Quality
 -0.21 1.18 0.93 1.18 0.51
Currency in USD